Bioorganic & Medicinal Chemistry 2004-01-15

Combining NMR and molecular modelling in a drug delivery context: investigation of the multi-mode inclusion of a new NPY-5 antagonist bromobenzenesulfonamide into beta-cyclodextrin.

Gloria Uccello-Barretta, Federica Balzano, Giuseppe Sicoli, Carmen Fríglola, Ignacio Aldana, Antonio Monge, Donatella Paolino, Salvatore Guccione

Index: Bioorg. Med. Chem. 12(2) , 447-58, (2004)

Full Text: HTML

Abstract

NMR spectroscopic and molecular modelling methods have been employed to describe the complexation of trans-N-4-[N'-(4-chlorobenzoyl)hydrazinocarbonyl]cyclohexylmethyl-4-bromobenzenesulfonamide, a new chemotype of NPY-5 antagonist, and beta-cyclodextrin, revealing the coexistence of two different kinds of 1:1 complexes where conformational changes of the guest compound with respect to the free state are also detected.

Related Compounds

  • 4-Bromobenzenesulf...

Related Articles:

Synthesis and biological evaluation of linear phenylethynylbenzenesulfonamide regioisomers as cyclooxygenase-1/-2 (COX-1/-2) inhibitors.

2006-08-01

[Bioorg. Med. Chem. 14(15) , 5259-65, (2006)]

Metabolites of ebrotidine, a new H2-receptor antagonist, in human urine.

1994-02-01

[J. Pharm. Sci. 83(2) , 252-4, (1994)]

Determination of ebrotidine metabolites in overlapping peaks from capillary zone electrophoresis using chemometric methods.

2001-01-01

[Electrophoresis 22(1) , 71-6, (2001)]

Preparation of novel cobalt (III) complexes with dithiocarbimates derived from sulfonamides. Oliveira MRL and Bellis VMD.

[Transit. Met. Chem. 24(2) , 127-130, (1999)]

More Articles...